RT Journal
A1 Mitka M
T1 ONcology drugs enter the us market faster than in europe but cost more
JF JAMA
JO JAMA
YR 2012
FD August 8
VO 308
IS 6
SP 555
OP 555
DO 10.1001/jama.2012.9535
UL http://dx.doi.org/10.1001/jama.2012.9535
AB 
The analysis found that oncology drug prices are on average 9% lower in the 4 European countries examined than in the United States. And the amount of the cost borne by patients is significantly lower in these countries than in the United States. The Tufts report estimated that US patients' coinsurance rates per covered drug was 33%. In contrast, patients pay a maximum of $13 per prescription in Germany and $10 per prescription in the United Kingdom. In France and the Netherlands, patients have no out-of-pocket payments for cancer drugs.